Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance

作者: Ji Young Yhee , Seungyong Song , So Jin Lee , Sung-Gurl Park , Ki-Suk Kim

DOI: 10.1016/J.JCONREL.2014.11.019

关键词: ChitosanPharmacologySmall interfering RNAGene silencingCancer cellCombination therapyCancerIn vivoChemistryDoxorubicin

摘要: P-glycoprotein (Pgp) mediated multi-drug resistance (MDR) is a major cause of failure in chemotherapy. In this study, small interfering RNA (siRNA) for Pgp down-regulation was delivered to tumors overcome MDR cancer. To achieve an efficient siRNA delivery vivo, self-polymerized 5'-end thiol-modified (poly-siRNA) incorporated tumor targeting glycol chitosan nanoparticles. Pgp-targeted poly-siRNA (psi-Pgp) and thiolated polymers (tGC) formed stable nanoparticles (psi-Pgp-tGC NPs), the resulting protected molecules from enzymatic degradation. The psi-Pgp-tGC NPs could release functional after cellular delivery, they were able facilitate Adriamycin-resistant breast cancer cells (MCF-7/ADR). After intravenous administration, accumulated MCF-7/ADR down-regulated P-gp expression sensitize cells. Consequently, chemo-siRNA combination therapy significantly inhibited growth without systemic toxicity. These showed great potential as supplementary therapeutic agent drug-resistant

参考文章(35)
Shigeru Tsukagoshi, Harumi Iida, Yoshio Sakurai, Takashi Tsuruo, Overcoming of Vincristine Resistance in P388 Leukemia in Vivo and in Vitro through Enhanced Cytotoxicity of Vincristine and Vinblastine by Verapamil Cancer Research. ,vol. 41, pp. 1967- 1972 ,(1981)
Ezharul Hoque Chowdhury, Li, Chu, Kunnath, Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs International Journal of Nanomedicine. ,vol. 7, pp. 2473- 2481 ,(2012) , 10.2147/IJN.S30500
Valery Alakhov, Evgueni Klinski, Shengmin Li, Grzegorz Pietrzynski, Annie Venne, Elena Batrakova, Tatiana Bronitch, Alexander Kabanov, Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials Colloids and Surfaces B: Biointerfaces. ,vol. 16, pp. 113- 134 ,(1999) , 10.1016/S0927-7765(99)00064-8
So Jin Lee, Sejin Son, Ji Young Yhee, Kuiwon Choi, Ick Chan Kwon, Sun Hwa Kim, Kwangmeyung Kim, Structural modification of siRNA for efficient gene silencing. Biotechnology Advances. ,vol. 31, pp. 491- 503 ,(2013) , 10.1016/J.BIOTECHADV.2012.09.002
Won Keun Oh, Kyoung Bin Cho, Tran Thi Hien, Tae Hyung Kim, Hyung Sik Kim, Trong Tuan Dao, Hyo-Kyung Han, Seong-Min Kwon, Sang-Gun Ahn, Jung-Hoon Yoon, Tae Hyun Kim, Yoon Gyoon Kim, Keon Wook Kang, Amurensin G, a Potent Natural SIRT1 Inhibitor, Rescues Doxorubicin Responsiveness via Down-Regulation of Multidrug Resistance 1 Molecular Pharmacology. ,vol. 78, pp. 855- 864 ,(2010) , 10.1124/MOL.110.065961
Chung-Pu Wu, Chia-Hung Hsieh, Yu-Shan Wu, The emergence of drug transporter-mediated multidrug resistance to cancer chemotherapy. Molecular Pharmaceutics. ,vol. 8, pp. 1996- 2011 ,(2011) , 10.1021/MP200261N
So Jin Lee, Ji Young Yhee, Sun Hwa Kim, Ick Chan Kwon, Kwangmeyung Kim, Biocompatible gelatin nanoparticles for tumor-targeted delivery of polymerized siRNA in tumor-bearing mice Journal of Controlled Release. ,vol. 172, pp. 358- 366 ,(2013) , 10.1016/J.JCONREL.2013.09.002
A.-L. Bolcato-Bellemin, M.-E. Bonnet, G. Creusat, P. Erbacher, J.-P. Behr, Sticky overhangs enhance siRNA-mediated gene silencing Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 16050- 16055 ,(2007) , 10.1073/PNAS.0707831104
Yogesh B. Patil, Suresh K. Swaminathan, Tanmoy Sadhukha, Linan Ma, Jayanth Panyam, The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. Biomaterials. ,vol. 31, pp. 358- 365 ,(2010) , 10.1016/J.BIOMATERIALS.2009.09.048
Sania Mansouri, Yan Cuie, Francoise Winnik, Qin Shi, Patrick Lavigne, Mohamed Benderdour, Eric Beaumont, Julio C. Fernandes, Characterization of folate-chitosan-DNA nanoparticles for gene therapy Biomaterials. ,vol. 27, pp. 2060- 2065 ,(2006) , 10.1016/J.BIOMATERIALS.2005.09.020